|
1
|
Rothschild E and Banerjee D: Subverting
subversion: A review on the breast cancer microenvironment and
therapeutic opportunities. Breast Cancer (Auckl). 9(Suppl 2):
S7–S15. 2015.
|
|
2
|
Wen KY, Fang CY and Ma GX: Breast cancer
experience and survivorship among Asian Americans: A systematic
review. J Cancer Surviv. 8:94–107. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gupta A, Shridhar K and Dhillon PK: A
review of breast cancer awareness among women in India: Cancer
literate or awareness deficit? Eur J Cancer. 51:2058–2066. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Alizadeh F, Bolhassani A, Khavari A,
Bathaie SZ, Naji T and Bidgoli SA: Retinoids and their biological
effects against cancer. Int Immunopharmacol. 18:43–49. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gerber B, Marx M, Untch M and Faridi A:
Breast reconstruction following cancer treatment. Dtsch Arztebl
Int. 112:593–600. 2015.PubMed/NCBI
|
|
6
|
Danilak M and Chambers CR: Adherence to
adjuvant endocrine therapy in women with breast cancer. J Oncol
Pharm Pract. 19:105–110. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Krastev TK, Jonasse Y and Kon M:
Oncological safety of autologous lipoaspirate grafting in breast
cancer patients: A systematic review. Ann Surg Oncol. 20:111–119.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Alkatout I, Order B, Klapper W, Weigel MT,
Jonat W, Schaefer FK, Mundhenke C and Wenners A: Surgical impact of
new treatments in breast cancer. Minerva Ginecol. 65:363–383.
2013.PubMed/NCBI
|
|
9
|
Hong IS, Jang GB, Lee HY and Nam JS:
Targeting cancer stem cells by using the nanoparticles. Int J
Nanomedicine. 10:251–260. 2015.PubMed/NCBI
|
|
10
|
Bao B, Azmi AS, Ali S, Zaiem F and Sarkar
FH: Metformin may function as anti-cancer agent via targeting
cancer stem cells: The potential biological significance of
tumor-associated miRNAs in breast and pancreatic cancers. Ann
Transl Med. 2:592014.PubMed/NCBI
|
|
11
|
Patel S, Shah K, Mirza S, Daga A and Rawal
R: Epigenetic regulators governing cancer stem cells and
epithelial-mesenchymal transition in oral squamous cell carcinoma.
Curr Stem Cell Res Ther. 10:140–152. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Menendez JA and Alarcón T: Metabostemness:
A new cancer hallmark. Front Oncol. 4:2622014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Anfuso B, Tiribelli C and Sukowati CH:
Recent insights into hepatic cancer stem cells. Hepatol Int.
8(Suppl 2): S458–S463. 2014. View Article : Google Scholar
|
|
14
|
Cherciu I, Bărbălan A, Pirici D,
Mărgăritescu C and Săftoiu A: Stem cells, colorectal cancer and
cancer stem cell markers correlations. Curr Health Sci J.
40:153–161. 2014.PubMed/NCBI
|
|
15
|
Adorno-Cruz V, Kibria G, Liu X, Doherty M,
Junk DJ, Guan D, Hubert C, Venere M, Mulkearns-Hubert E, Sinyuk M,
et al: Cancer stem cells: Targeting the roots of cancer, seeds of
metastasis and sources of therapy resistance. Cancer Res.
75:924–929. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Stecklein SR, Jensen RA and Pal A: Genetic
and epigenetic signatures of breast cancer subtypes. Front Biosci
(Elite Ed). 4:934–949. 2012.PubMed/NCBI
|
|
17
|
Mannelli G and Gallo O: Cancer stem cells
hypothesis and stem cells in head and neck cancers. Cancer Treat
Rev. 38:515–539. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Podberezin M, Wen J and Chang CC: Cancer
stem cells: A review of potential clinical applications. Arch
Pathol Lab Med. 137:1111–1116. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zvereva MI, Shcherbakova DM and Dontsova
OA: Telomerase: Structure, functions, and activity regulation.
Biochemistry (Mosc). 75:1563–1583. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Blomme J, Inzé D and Gonzalez N: The
cell-cycle interactome: A source of growth regulators? J Exp Bot.
65:2715–2730. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sheppard KE and McArthur GA: The
cell-cycle regulator CDK4: An emerging therapeutic target in
melanoma. Clin Cancer Res. 19:5320–5328. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Poss ZC, Ebmeier CC and Taatjes DJ: The
Mediator complex and transcription regulation. Crit Rev Biochem Mol
Biol. 48:575–608. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Safa AR, Saadatzadeh MR, Cohen-Gadol AA,
Pollok KE and Bijangi-Vishehsaraei K: Glioblastoma stem cells
(GSCs) epigenetic plasticity and interconversion between
differentiated non-GSCs and GSCs. Genes Dis. 2:152–163. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Suhardja A and Hoffman H: Role of growth
factors and their receptors in proliferation of microvascular
endothelial cells. Microsc Res Tech. 60:70–75. 2013. View Article : Google Scholar
|
|
25
|
Park J, Kim HN, Kim DH, Levchenko A and
Suh KY: Quantitative analysis of the combined effect of substrate
rigidity and topographic guidance on cell morphology. IEEE Trans
Nanobioscience. 11:28–36. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Qin L, Huang J, Xiong C, Zhang Y and Fang
J: Dynamical stress characterization and energy evaluation of
single cardiac myocyteactuating on flexible substrate. Biochem
Biophys Res Commun. 360:352–356. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kumar P, Kadakol A, Shasthrula PK, Mundhe
NA, Jamdade VS, Barua CC and Gaikwad AB: Curcumin as an adjuvant to
breast cancer treatment. Anticancer Agents Med Chem. 15:647–656.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zeineddine D, Hammoud AA, Mortada M and
Boeuf H: The Oct4 protein: More than a magic stemness marker. Am J
Stem Cells. 3:74–82. 2014.PubMed/NCBI
|
|
29
|
Lyons AB, Blake SJ and Doherty KV: Flow
cytometric analysis of cell division by dilution of CFSE and
related dyes. Curr Protoc Cytom. 9:Unit9.112013.PubMed/NCBI
|
